BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 2579784)

  • 21. Transdermal buprenorphine in cancer pain and palliative care.
    Sittl R
    Palliat Med; 2006; 20 Suppl 1():s25-30. PubMed ID: 16764218
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Buprenorphine (Temgesic) as a peroperative analgesic. A multicenter study].
    Abrahamsson J; Niemand D; Olsson AK; Törnebrandt K
    Anaesthesist; 1983 Feb; 32(2):75-9. PubMed ID: 6342461
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effectiveness and tolerability of the buprenorphine transdermal system in patients with moderate to severe chronic pain: a multicenter, open-label, uncontrolled, prospective, observational clinical study.
    Muriel C; Failde I; Micó JA; Neira M; Sánchez-Magro I
    Clin Ther; 2005 Apr; 27(4):451-62. PubMed ID: 15922818
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Equipotent doses of transdermal fentanyl and transdermal buprenorphine in patients with cancer and noncancer pain: results of a retrospective cohort study.
    Sittl R; Likar R; Nautrup BP
    Clin Ther; 2005 Feb; 27(2):225-37. PubMed ID: 15811486
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Switching from transdermal drugs: an observational "N of 1" study of fentanyl and buprenorphine.
    Mercadante S; Porzio G; Fulfaro F; Aielli F; Verna L; Ficorella C; Casuccio A; Riina S; Intravaia G; Mangione S
    J Pain Symptom Manage; 2007 Nov; 34(5):532-8. PubMed ID: 17629666
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Treatment of cancer pain by continuous subcutaneous infusion of buprenorphine].
    Umeda S; Noda J; Arai T; Omatsu Y; Moriyama S; Harima A
    Gan No Rinsho; 1986 May; 32(5):497-500. PubMed ID: 3723808
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Sublingual buprenorphine in the therapy of postoperative pain].
    Tolksdorf W; Bangert J; Glocke M; Müller W
    Anasth Intensivther Notfallmed; 1984 Jun; 19(3):117-23. PubMed ID: 6476299
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Moradol in the pain syndrome of cancer patients].
    Voznyĭ EK; Goncharenko GV; D'iachkova LV; Panshin GA; Shafir II
    Sov Med; 1988; (3):113-5. PubMed ID: 3413544
    [No Abstract]   [Full Text] [Related]  

  • 29. Opioid rotation from high-dose morphine to transdermal buprenorphine (Transtec) in chronic pain patients.
    Freye E; Anderson-Hillemacher A; Ritzdorf I; Levy JV
    Pain Pract; 2007 Jun; 7(2):123-9. PubMed ID: 17559481
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Safety and effectiveness of intravenous morphine for episodic breakthrough pain in patients receiving transdermal buprenorphine.
    Mercadante S; Villari P; Ferrera P; Porzio G; Aielli F; Verna L; Casuccio A
    J Pain Symptom Manage; 2006 Aug; 32(2):175-9. PubMed ID: 16877185
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Management of chronic cancer pain using a computerized ambulatory patient-controlled analgesia pump.
    Wagner JC; Souders GD; Coffman LK; Horvath JL
    Hosp Pharm; 1989 Aug; 24(8):639-40, 642-4. PubMed ID: 10294360
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Early postoperative treatment of pain with buprenorphine].
    Gundersen Y; Andersen R; Alver T
    Tidsskr Nor Laegeforen; 1984 Sep; 104(25):1717-20. PubMed ID: 6385337
    [No Abstract]   [Full Text] [Related]  

  • 33. [Sublingual buprenorphine (Temgesic) for the management of postoperative pain. A comparative study of intramuscular pethidine and buprenorphine].
    Crawford ME; Carl P; Bøggild-Madsen NB; Ravlo O; Bach V; Larsen AI; Kruse L
    Ugeskr Laeger; 1985 Jun; 147(23):1842-5. PubMed ID: 3895692
    [No Abstract]   [Full Text] [Related]  

  • 34. Clinical use of buprenorphine in chronic administration.
    Adriaensen H; Van De Walle J
    Acta Anaesthesiol Belg; 1976; 27(3):187-91. PubMed ID: 801583
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Buprenorphine injection (Temgesic).
    Drug Ther Bull; 1979 Mar; 17(5):17-9. PubMed ID: 421663
    [No Abstract]   [Full Text] [Related]  

  • 36. Transdermal buprenorphine in clinical practice--a post-marketing surveillance study in 13,179 patients.
    Griessinger N; Sittl R; Likar R
    Curr Med Res Opin; 2005 Aug; 21(8):1147-56. PubMed ID: 16083522
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of analgesic activity of buprenorphine hydrochloride and morphine in patients with moderate to severe pain postoperatively.
    Ouellette RD
    Surg Gynecol Obstet; 1984 Sep; 159(3):201-6. PubMed ID: 6474320
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Buprenorphine and nicomorphine in a double-blind trial for the control of postoperative pain (author's transl)].
    Ravjower I; Alon E; Hossli G
    Anasth Intensivther Notfallmed; 1981 Dec; 16(6):340-2. PubMed ID: 7325347
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Comparison between the analgesic effects of buprenorphine and morphine in conscious man (author's transl)].
    Cathelin M; Vignes R; Viars P
    Anesth Analg (Paris); 1980; 37(5-6):275-82. PubMed ID: 7457947
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Temgesic sublingual.
    Johnson LF
    N Z Med J; 1985 Jan; 98(771):27. PubMed ID: 3855518
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.